The World Health Organization (WHO) has published its first guidelines on the care of adults living with type 1 diabetes, aiming to make life-saving insulin treatment and glucose monitoring available to everyone, wherever they live.
Released around World Diabetes Day on 14 November 2026, the guidelines contain 14 recommendations. They strongly recommend intensified insulin therapy, meaning multiple daily injections adjusted to blood glucose levels, and set out advice on insulin types, pens versus syringes, HbA1c testing, home glucose monitoring and self-management education. For the first time, WHO also includes specific guidance for humanitarian and emergency settings, where insulin supplies and cold storage can be disrupted. About 9.5 million people worldwide were living with type 1 diabetes in 2025, and up to half are diagnosed as adults.

Imagine a 34-year-old teacher in Uganda who was diagnosed with diabetes two years ago and told it was type 2. Tablets did not help, she kept losing weight, and she ended up in hospital twice with diabetic ketoacidosis. Eventually a nurse at a district hospital recognised the signs of type 1 diabetes and started her on insulin, teaching her to check her blood glucose and adjust her doses around meals. For the first time in years, she feels in control. WHO’s new guidelines aim to make this kind of care, accurate diagnosis, the right insulin, monitoring and education, the standard for every adult with type 1 diabetes.
What happened
WHO issued the guidelines in a press release dated 14 November 2026, World Diabetes Day. They are the organisation’s first dedicated guidance on managing type 1 diabetes in adults, a condition historically associated with childhood but which, in up to half of cases, is diagnosed in adulthood.
The guidelines include 14 recommendations. The central one is a strong recommendation for intensified insulin therapy, usually three or more injections a day combining a long-acting (basal) insulin with mealtime (bolus) insulin, adjusted according to glucose readings, carbohydrate intake and physical activity.
WHO also recommends regular HbA1c testing, home glucose monitoring using finger-prick tests or continuous glucose monitors where available, and education so that people can safely adjust their own insulin. Separate advice covers humanitarian and emergency settings.
10 key facts
- WHO has published its first guidelines on type 1 diabetes in adults.
- They were released around World Diabetes Day, 14 November 2026.
- There are 14 recommendations in total.
- Intensified insulin therapy is strongly recommended.
- Human insulin or insulin analogues may be used; human insulin may be preferred where cheaper.
- Insulin pens are suggested over syringes, but syringes remain acceptable.
- HbA1c should be tested at least every three months, with a target of 7% or lower for most adults.
- Home glucose monitoring and self-management education are central.
- There is specific advice for humanitarian and emergency settings.
- About 9.5 million people were living with type 1 diabetes in 2025.
The numbers at a glance
- About 9.5 million people with type 1 diabetes worldwide (2025)
- More than 500,000 new diagnoses in 2025
- Up to half diagnosed in adulthood
- Up to 40% of cases in low-income settings first misdiagnosed as type 2
- 14 recommendations in the new guidelines
- HbA1c testing at intervals of up to three months
- HbA1c target of 7% or lower for most adults
- Remaining life expectancy for a 10-year-old diagnosed in 2025: about 6 years in very disadvantaged countries, over 60 years elsewhere (Type 1 Diabetes Index)
- Global 2030 target: 100% access to affordable insulin and glucose self-monitoring
What is type 1 diabetes?
Type 1 diabetes is an autoimmune condition in which the immune system destroys the insulin-producing cells of the pancreas. Without insulin, the body cannot move glucose from the blood into cells for energy. People with type 1 diabetes need insulin every day to survive.
It differs from type 2 diabetes, which is far more common and usually develops when the body becomes resistant to insulin or doesn’t make enough. Type 2 can often be managed initially with lifestyle changes and tablets.
Type 1 diabetes can start at any age. Symptoms include extreme thirst, passing a lot of urine, weight loss, tiredness and blurred vision. Without treatment, it can lead to diabetic ketoacidosis, a life-threatening emergency. In adults, it is often mistaken for type 2 diabetes, delaying insulin.
Why this matters
Until now, much of the global guidance on type 1 diabetes focused on children. Yet many people are diagnosed as adults, and in low-income settings up to 40% are first misdiagnosed as having type 2 diabetes. These guidelines give health systems a clear, evidence-based standard for adult care.
Where a person lives still largely decides their survival. The Type 1 Diabetes Index estimates that a 10-year-old diagnosed in 2025 may expect to live only about six more years in the most disadvantaged countries, compared with over 60 years elsewhere.
The guidelines are also practical. Recognising that human insulin may be cheaper, that syringes are sometimes all that is available, and that blood glucose testing may be limited, WHO offers options that health systems with fewer resources can implement.
What officials and experts said
Dr Bianca Hemmingsen, technical lead of WHO’s Diabetes Programme, said the aim is that ‘everyone living with type 1 diabetes can access quality, lifesaving care, wherever they live’.
Dr Peter Schwarz, President of the International Diabetes Federation (IDF), said: ‘For people with type 1 diabetes, insulin is a matter of survival.’ He added that ‘where a child is born still largely decides whether they will live a long, healthy life with the condition’.
The guidelines’ executive summary notes that adults with type 1 diabetes often face ‘fragmented care, limited access to specialist support and inconsistent follow-up’.
What this means for you
- If you live with type 1 diabetes, ask whether a multiple daily injection plan suits you.
- Ask how often your HbA1c should be checked and what your target is.
- Learn to adjust insulin for meals, activity and illness with support from your care team.
- Ask about continuous glucose monitors if they are available and affordable.
- Keep a supply plan for emergencies, including how to store insulin safely.
- If you were diagnosed with type 2 diabetes but tablets are not working, ask whether type 1 has been considered.
What this means for nurses and health workers
Diabetes specialist nurses and primary care nurses are key to putting these guidelines into practice, especially where specialists are scarce.
- Teach insulin injection technique and safe storage.
- Support people to interpret glucose readings and adjust doses.
- Check HbA1c regularly and review targets.
- Recognise and act on signs of ketoacidosis and hypoglycaemia.
- Consider type 1 diabetes in adults who are thin, losing weight or not responding to tablets.
- Plan for supply interruptions in emergencies.
The global picture
Diabetes-related premature deaths have kept rising worldwide, unlike most other major noncommunicable diseases. In conflict settings such as Sudan, the IDF reports that over 60% of health facilities are not functioning, and the collapse of the power grid threatens insulin cold storage. WHO Member States have endorsed a target that, by 2030, 100% of people with type 1 diabetes should have access to affordable insulin and blood glucose self-monitoring.
Advice for humanitarian and emergency settings
Recognising that crises often disrupt insulin supplies, WHO recommends that providers use intensified therapy where possible, but have contingency plans to switch temporarily to simpler regimens when supplies are uncertain. The choice of insulin should take into account the reliability and sustainability of local supply, not only cost. Priorities include access to glucose monitoring, training health workers and supporting self-management. WHO acknowledges that most evidence comes from stable settings, leaving gaps in knowledge for emergencies.
Pens or syringes?
WHO suggests insulin pens rather than syringes where available, but this is a conditional recommendation based on very low-certainty evidence. Syringes remain an acceptable choice where pens are not available or affordable.
Glucose monitoring options
Options include finger-prick blood glucose testing and continuous glucose monitoring, either real-time or intermittently scanned. Where blood testing is not possible, urine glucose testing is an alternative, though less precise.
Self-management education
Teaching people to understand their readings and adjust insulin safely is especially important where trained clinicians are scarce. Education reduces emergencies and improves day-to-day control.
Implementing the guidelines
WHO urges countries to include the recommendations in national diabetes policies, essential medicines lists and training, and to involve people with type 1 diabetes in planning programmes. WHO will provide tools to track progress.
Hypoglycaemia safety
Low blood glucose is a risk with insulin. People should know the signs, such as shakiness, sweating and confusion, carry fast-acting sugar, and make sure family know what to do.
Myths and facts
Myth: Type 1 diabetes only affects children.
Fact: Up to half of cases are diagnosed in adults.
Myth: Type 1 diabetes can be managed with tablets.
Fact: It always needs insulin.
Myth: Only expensive insulin works.
Fact: Human insulin is effective and may be preferred where cheaper.
Myth: Pens are essential.
Fact: Syringes remain acceptable where pens are unavailable.
Questions and answers
What is new in these guidelines?
They are WHO’s first focused on adults with type 1 diabetes.
What insulin plan is recommended?
Intensified therapy with multiple daily injections adjusted to glucose.
How often should HbA1c be checked?
At intervals of up to three months.
What is the HbA1c target?
7% or lower for most adults.
Are glucose monitors required?
Finger-prick testing or continuous monitors are recommended where available.
What about emergencies?
Have contingency plans for simpler regimens if supply is disrupted.
Do the guidelines cover children?
No, these focus on adults.
What happens next
WHO will support countries to adapt the guidelines and track progress towards the 2030 targets on insulin and glucose monitoring access. Health ministries, professional bodies and diabetes organisations are expected to review national protocols and training in response.
Key takeaways
- WHO has published its first guidelines on type 1 diabetes in adults.
- There are 14 recommendations in total.
- Human insulin or insulin analogues may be used; human insulin may be preferred where cheaper.
- HbA1c should be tested at least every three months, with a target of 7% or lower for most adults.
- There is specific advice for humanitarian and emergency settings.
- About 9.5 million people were living with type 1 diabetes in 2025.
How we report health news
Nursing Media Network reports health news using official sources such as the World Health Organization, national public health agencies, medicines regulators and peer-reviewed research, which are linked at the end of each story. Figures in fast-moving stories, such as outbreaks, change quickly, so we state the date each number refers to. If you are reading this later, check the latest update from the official source before making decisions.
News reports describe what has happened across a population. They cannot tell you what is right for your own health. If a story raises questions about your treatment, symptoms or risk, speak to your nurse or healthcare provider before making any changes.
Finding reliable health information
Health information online varies widely in quality. Prefer sources such as the World Health Organization, national health ministries, public health agencies, university hospitals and registered professional bodies. Be cautious with social media posts, miracle cures and products sold with promises that sound too good to be true.
If you read something that worries you or contradicts the advice you have been given, write it down and discuss it with your nurse or healthcare provider. They can explain how it applies to your own situation and help you separate evidence from rumour.
Questions to ask your nurse or healthcare provider
- Is my insulin plan right for me?
- How often should my HbA1c be checked?
- Can I get a continuous glucose monitor?
- How do I adjust insulin when I’m ill?
- What should I do if insulin supply is interrupted?
- Could I have been misdiagnosed with type 2 diabetes?
But aren’t most adults with diabetes type 2?
Most are, but up to half of type 1 cases start in adulthood. Getting the type right means getting the right treatment.
Your next step: If you live with type 1 diabetes, book a review with your diabetes nurse to discuss your insulin plan, HbA1c target and glucose monitoring.
Related: Type 1 diabetes · Hypoglycaemia · Type 2 diabetes
Sources: Health Policy Watch, 19 November 2026; WHO news releases, November 2026; WHO: diabetes.



Leave a Reply